Dr Reddys settles patent litigation over cancer drug Revlimid with Celgene in US Ruchika Sharma19 Sept 2020 9:45 AM ISTRevlimid is used to treat multiple myeloma and myelodysplastic syndromes.
Indoco Remedies Blood-thinner Apixaban gets USFDA green flag Ruchika Sharma14 Sept 2020 3:02 PM ISTIt is used for patients with health problems caused by a blood clot.
Indoco Remedies Blood-thinner Apixaban gets USFDA green flag Ruchika Sharma14 Sept 2020 3:02 PM ISTIt is used for patients with health problems caused by a blood clot.
Bristol Myers Squibb Onureg gets USFDA approval to treat Acute Myeloid Leukemia Medical Dialogues Bureau12 Sept 2020 9:15 AM ISTPrinceton: Bristol Myers Squibb recently announced that the U.S. Food and Drug Administration (FDA) has approved Onureg (azacitidine 300 mg tablets,...
Bristol Myers Squibb Onureg gets USFDA nod to treat Acute Myeloid Leukemia Ruchika Sharma3 Sept 2020 9:45 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved Onureg® (azacitidine 300 mg...
Bristol Myers, Dragonfly Therapeutics enter global licensing agreement for IL-12 Investigational Immunotherapy Program Ruchika Sharma20 Aug 2020 9:00 AM ISTNew York & Waltham: Bristol Myers Squibb and Dragonfly Therapeutics, Inc., have announced that they have entered into a definitive...
Bristol Myers anticipates recovery in sales of hospital-administered drugs, raises annual profit forecast Ruchika Sharma9 Aug 2020 9:15 AM ISTUS: Bristol Myers Squibb Co (BMY.N) on Thursday raised its annual profit forecast as it predicted a recovery in sales of its...
Bristol Myers Squibb CAR T Cell Therapy Lisocabtagene Maraleucel gets EMA validation Medical Dialogues Bureau2 Aug 2020 9:30 AM ISTPrincton: Bristol Myers Squibb (NYSE: BMY) recently announced that the European Medicines Agency (EMA) has validated its Marketing Authorization...
Natco Pharma, Celgene ink pact for cancer treatment drug Lenalidomide Ruchika Sharma11 July 2020 12:47 PM ISTLenalidomide is used to treat various types of cancers.
Bristol Myers Squibb gets EMA validation for Idecabtagene Vicleucel, CC-486 Ruchika Sharma25 May 2020 3:53 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Applications (MAA)...
Bristol Myers gets USFDA nod to Opdivo, Yervoy combo for treating Lung Cancer Patients Farhat Nasim18 May 2020 5:18 PM ISTNew Delhi: Bristol Myers Squibb(BMS) recently announced that Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab) 1 mg/kg (injections for...
USFDA extends action date for Bristol Myers Squibb Lisocabtagene Maraleucel (liso-cel) Ruchika Sharma10 May 2020 12:15 PM ISTLiso-cel is an investigational chimeric antigen receptor (CAR) T-cell therapy designed to target CD19
